Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 2
2022 7
2023 3
2024 4
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 33035622

18 results

Results by year

Filters applied: . Clear all
Page 1
Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control.
Levin-Epstein RG, Jiang NY, Wang X, Upadhyaya SK, Collins SP, Suy S, Aghdam N, Mantz C, Katz AJ, Miszczyk L, Napieralska A, Namysl-Kaletka A, Prionas N, Bagshaw H, Buyyounouski MK, Cao M, Agazaryan N, Dang A, Yuan Y, Kupelian PA, Zaorsky NG, Spratt DE, Mohamad O, Feng FY, Mahal BA, Boutros PC, Kishan AU, Juarez J, Shabsovich D, Jiang T, Kahlon S, Patel A, Patel J, Nickols NG, Steinberg ML, Fuller DB, Kishan AU. Levin-Epstein RG, et al. Radiother Oncol. 2021 Jan;154:207-213. doi: 10.1016/j.radonc.2020.09.053. Epub 2020 Oct 7. Radiother Oncol. 2021. PMID: 33035622 Free PMC article.
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial.
Bonù ML, Magli A, Tomasini D, Frassine F, Albano D, Arcangeli S, Bruni A, Ciccarelli S, De Angeli M, Francolini G, Franzese C, Ghirardelli P, Grazioli L, Guerini A, Lancia A, Marvaso G, Sepulcri M, Trodella LE, Morelli V, Georgopulos A, Domina AO, Granello L, Mataj E, Barbera F, Triggiani L. Bonù ML, et al. BJR Open. 2022 Nov 29;4(1):20220032. doi: 10.1259/bjro.20220032. eCollection 2022. BJR Open. 2022. PMID: 38525170 Free PMC article.
Stereotactic body radiotherapy for distant metastases to the head and neck.
Mutsaers A, Abugharib A, Poon I, Loblaw J, Bayley A, Zhang L, Chin L, Galapin M, Erler D, Sahgal A, Higgins K, Enepekides D, Eskander A, Karam I. Mutsaers A, et al. Support Care Cancer. 2024 Mar 15;32(4):230. doi: 10.1007/s00520-024-08419-0. Support Care Cancer. 2024. PMID: 38488881
Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial.
Borzillo V, Scipilliti E, Pezzulla D, Serra M, Ametrano G, Quarto G, Perdonà S, Rossetti S, Pignata S, Crispo A, Di Gennaro P, D'Alesio V, Arrichiello C, Buonanno F, Mercogliano S, Russo A, Tufano A, Di Franco R, Muto P. Borzillo V, et al. Front Oncol. 2023 Nov 7;13:1270498. doi: 10.3389/fonc.2023.1270498. eCollection 2023. Front Oncol. 2023. PMID: 38023175 Free PMC article.
18 results